Replies to post #2282 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

Yes Spideyboy you're right cure does not fit here. English for me is a foreign language and I confuse words.It's one more thing. CC in the latest article says that Pfizer' Elelyso sales in 2016 account for 0.7% of the Gaucher market (Source: Excel plot of the above table). I do not know about this source and think this is not true.Let's assume this market in 2016 was approximately $1.2 B hence the Pfizer' sales amounted to $8.4M but the Protalix' Elelyso sales to Pfizer this year were $5M (my post # 2238). That is, these numbers are absolutely not convergent. If you Google "Global Gaucher Disease Market " you will find that in many researches Pfizer is mentioned among the 4 main players.So we will leave all this on the conscience of this analyst.